Key Takeaways
- Starting 20 April 2025, Australian Red Cross Lifeblood will use a gender‑neutral pre‑donation questionnaire, asking all donors the same questions about recent sexual activity.
- The change follows Therapeutic Goods Administration (TGA) approval last year to remove gender‑based sexual‑activity rules that dated back to the HIV pandemic of the 1980s.
- Lifeblood estimates the update could generate up to 20,000 additional blood and platelet donations per year.
- Early adopters, such as plasma donor Luke Moorcraft, welcome the move as both safe and inclusive, noting personal motivations tied to family health experiences and frontline work.
- Lifeblood will continue to review eligibility criteria and scientific evidence to maintain the safety of the blood supply while broadening donor inclusion.
Background
Australian Red Cross Lifeblood has long regulated who may give blood based on factors intended to protect recipients from transfusion‑transmissible infections. For decades, men who have sex with men (MSM) and certain transgender individuals faced deferral periods or outright bans rooted in the early HIV/AIDS crisis. These policies were periodically reviewed, but substantive reform remained elusive until recent scientific evidence showed that individual risk‑based assessment could safeguard the supply without blanket exclusions.
Policy Change Details
Effective 20 April 2025, Lifeblood replaces its gender‑specific sexual‑activity questions with a single, gender‑neutral set that all prospective donors must answer. The new questionnaire focuses on behaviours—such as recent new or multiple sexual partners, condom use, and specific high‑risk activities—rather than the donor’s sex, gender identity, or sexual orientation. This shift aligns Australia with several other high‑income countries that have adopted individual risk‑assessment models for blood donation.
Implementation Process
Lifeblood worked closely with state and territory health authorities to update training materials, donor‑information brochures, and the electronic donation‑eligibility system used at all collection centres. Staff received briefings on the rationale behind the change and how to administer the new questions sensitively. The rollout began on the nominated date, with signage and digital prompts informing donors that everyone will be asked the same questions regardless of gender or sexual orientation.
Pre‑Donation Questionnaire Content
The revised form asks donors about: recent sexual activity with new or multiple partners; any occurrences of anal sex without a condom; use of pre‑exposure prophylaxis (PrEP) or post‑exposure prophylaxis (PEP); history of sexually transmitted infections; and any exposure to blood or bodily fluids through non‑sexual routes. Answers determine a temporary deferral if indicated risk is present, but the same criteria apply to every individual, removing the previous automatic deferral for MSM and transgender people.
Impact on the Donor Pool
Lifeblood’s executive director, Cath Stone, projects that the inclusive approach could yield as many as 20,000 extra blood and platelet donations annually. This estimate builds on earlier observations: when plasma‑donation waiting periods were lifted in July 2024, the organisation saw roughly 3,000 new donors contribute nearly 10,000 plasma units. By broadening eligibility for whole blood and platelets, Lifeblood hopes to alleviate periodic shortages, especially for high‑demand blood types and for patients undergoing chemotherapy, surgery, or trauma care.
Statement from Cath Stone
Stone emphasised that the change is both scientifically justified and socially overdue: “We’ve done a broad range of research to understand the best, least confusing way to ask the questions that are important safeguards around the safety of our blood supply.” She noted that the Therapeutic Goods Administration’s endorsement last year gave Lifeblood the confidence to proceed, and that ongoing monitoring will ensure the blood supply remains safe while expanding donor participation.
Community Reaction – Luke Moorcraft
Adelaide‑registered nurse Luke Moorcraft, who has been donating plasma since the plasma‑rule change, welcomed the new policy as a personal milestone. He shared that his motivation stems from watching family members battle cancer and from a decade of frontline emergency‑department work, where he witnessed the critical need for blood products. Moorcraft expressed optimism that many others in the LGBTQ+ community would now feel empowered to donate, reinforcing the idea that inclusivity boosts both the donor pool and public confidence in the health system.
Broader Advocacy and Public Response
Advocacy groups celebrating the modification highlighted its alignment with human‑rights principles and the removal of stigmatising barriers. They pointed out that the prior deferral contributed to feelings of exclusion among gay, bisexual, and transgender Australians, potentially discouraging engagement with other health services. The responses on social media and in community forums have been largely positive, with many noting that the change reflects contemporary epidemiology rather than outdated fears.
Safety and Research Basis
Lifeblood’s decision rests on recent epidemiological data showing that individual behavioural risk—rather than sexual orientation alone—predicts transfusion‑transmissible infection risk. Studies from the United Kingdom, Canada, and the United States, which adopted similar risk‑based models, have not demonstrated a rise in HIV or hepatitis B/C incidents post‑implementation. Lifeblood’s own modelling, incorporating Australia’s specific prevalence rates, forecast a negligible increase in risk while substantially raising donor numbers.
Historical Context
The earlier deferral for MSM originated in the mid‑1980s when HIV transmission through blood transfusions was a major public‑health threat, and reliable testing was limited. Over time, improvements in nucleic‑acid testing reduced the window period to days, yet the blanket bans persisted due to precautionary principles. Periodic reviews shortened the deferral from indefinite to 12 months, then to 3 months, before the current shift to behaviour‑based screening eliminated the categorical restriction altogether.
Comparison with Plasma‑Donation Changes
The plasma‑donation reform in July 2024, which removed waiting periods for frequent donors, served as a precursor to today’s broader adjustment. That change demonstrated that loosening certain eligibility criteria could safely increase donation volumes without compromising safety. The current expansion builds on that proof‑of‑concept, extending similar principles to whole‑blood and platelet donations, thereby maximising the potential donor base across all product types.
Future Steps and Ongoing Review
Lifeblood commits to continual reassessment of eligibility criteria, integrating emerging research, surveillance data, and feedback from donors and healthcare professionals. The organisation plans to publish periodic reports on donation numbers, safety metrics, and any observed trends in infection markers. This transparent approach aims to maintain public trust while ensuring that the blood supply remains both safe and sufficient for all patients who depend on it.
Conclusion
From 20 April 2025, Australian Red Cross Lifeblood’s adoption of a gender‑neutral, behaviour‑based screening questionnaire marks a significant step toward a more inclusive and scientifically grounded blood‑donation system. By dismantling outdated gender‑specific barriers, the initiative not only honours equity but also promises to bolster the nation’s blood reserves—potentially adding tens of thousands of donations each year. Early adopters like Luke Moorcraft illustrate the personal and societal benefits of the change, and ongoing vigilance will safeguard the health of recipients while welcoming a broader community of donors.